28
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1879L1 |
P11 acetate
|
Integrin | Cytoskeletal Signaling |
P11 acetate 是一种整合素 αvβ3-玻连蛋白相互作用拮抗剂 (IC50 = 2.74 nM)。 | |||
TP2326L |
Oligopeptide P11-4 acetate
Oligopeptide P11-4 acetate(593266-60-5 free base) |
Others | Others |
Oligopeptide P11-4 acetate(593266-60-5 free base) 是一种肽。 | |||
T34081 |
Piromelatine
NEU-P-11,NEU-P 11,NEU-P11 |
P2X Receptor; 5-HT Receptor; MT Receptor; Sodium Channel; TRP/TRPV Channel | GPCR/G Protein; Membrane transporter/Ion channel; Neuroscience |
Piromelatine 是褪黑激素 MT1/MT2 受体、5-HT1A 和 5-HT1D 的激动剂,也是 5-HT2B 的拮抗剂。Piromelatine 具有抗痛觉活性,对 P2X3、TRPV1 和 Nav1.7 通道有抑制作用,可用于促进睡眠、缓解疼痛、抗神经退行性疾病和抗抑郁疾病的研究。 | |||
TP1879 |
HSDVHK-NH2
P11 |
||
Potent antagonist of the integrin αvβ3-vitronectin interaction (IC50 = 25.72 nM). Blocks proliferation and induces apoptosis in HUVECs; antiangiogenic. | |||
T24586 |
PAFAH1b2
PAFAH-1-b-2,3-IN-P11,3INP11,3 IN P11,PAFAH 1 b 2 |
||
PAFAH1b2 is a selective platelet-activating factor acetylhydrolases 1b2 and 1b3 inhibitor that acts by impairing cancer cell survival. | |||
T10922 |
CYP11B2-IN-1
|
P450 | Metabolism |
CYP11B2-IN-1 是一种有效的选择性 CYP11B2 抑制剂,对 CYP11B2 和 CYP11B1 的 IC50 分别为 2.3 nM 和 142 nM。 | |||
T9596 |
AP1189 acetate
|
Melanocortin Receptor | GPCR/G Protein; Neuroscience |
AP1189 acetate 是黑皮质素 1 和黑皮质素 3 受体的偏向激动剂。 | |||
T16422 |
P110δ-IN-1
PWT-143 |
PI3K | PI3K/Akt/mTOR signaling |
P110δ-IN-1 (PWT-143) 是一种有效的、选择性的P110δ抑制剂,其 IC50=8.4 nM。 | |||
T3969 |
I-CBP112
|
Epigenetic Reader Domain; Histone Acetyltransferase | Chromatin/Epigenetic |
I-CBP112 是一种特异性的乙酰赖氨酸竞争性蛋白质-蛋白质相互作用抑制剂,靶向 CBP/p300 溴结构域,增强 p300 的乙酰化作用。 | |||
T4472 |
NMS-P118
|
PARP | Chromatin/Epigenetic; DNA Damage/DNA Repair |
NMS-P118是可口服的高选择性PARP-1抑制剂,用于癌症治疗,在HeLa 细胞中的IC50值为0.04 μM。 | |||
T7334 |
NP118809
39-1B4,1-【4-(二苯甲基)-1-哌嗪基】-3,3-二苯基-1-丙酮 |
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
NP118809 (39-1B4) 是 N 型钙通道阻滞剂,IC50值为 0.11 μM。它较弱地抑制 L 型钙通道,IC50值为 12.2 μM。 | |||
T24437 |
MCP110
MCP-110,MCP 110 |
Raf; Ras | GPCR/G Protein; MAPK |
MCP110 是 Ras 与 Raf-1 相互作用的抑制剂,可用于治疗人类肿瘤的研究。 | |||
T4247 |
I-CBP112 hydrochloride
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
I-CBP112 hydrochloride 是含溴结构域转录因子的选择性抑制剂,靶向 CBP/p300 溴结构域。在体内外,它以剂量依赖性方式显着降低 MLL-AF9(+) 急性髓细胞白血病细胞的白血病起始潜力,还增加 BET 溴结构域抑制剂 JQ1 以及阿霉素的细胞毒活性。 | |||
TP1947L |
P110 TFA
|
Others | Others |
P110 TFA 是一种 dynamin-related protein 1 (Drp1) 抑制剂,抑制 Drp1 GTPase 活性。 | |||
T64249 | CYP11B1-IN-2 | ||
CYP11B1-IN-2 (compound 7aa) 是一种选择性的、口服具有活力的 CYP11B1 抑制剂,能够作用于 human CYP11B1 (IC50: 9 nM) 和 rat CYP11B1 (IC50: 25 nM)。CYP11B1-IN-2 能够用于研究皮质醇过量所致疾病。 | |||
T15783 |
LP117
|
Others | Others |
LP117 is a novel and effective inhibitor of 5-Lipoxygenase (5-LO) product synthesis (IC50: 1.1 μM). | |||
T61329 |
HP1142
|
||
HP1142 is a highly effective and specific inhibitor targeting the FLT3 receptor tyrosine kinase, with a particular affinity for its mutant variant FLT3/ITD. It exhibits a benzoimidazole scaffold-based structure, making it a promising compound for investigating and studying the FLT3/ITD mutation in the context of leukemia research [1]. | |||
T40850 |
[D-Trp11]-Neurotensin
[D-Trp11]-Neurotensin |
||
[D-Trp11]-Neurotensin is a compound that functions as a selective antagonist of Neurotensin (NT) in perfused rat hearts, while exhibiting full agonist properties in guinea pig atria and rat stomach strips. Additionally, this compound can inhibit hypotension induced by NT. | |||
T78204 |
CYP11A1-IN-1
|
||
CYP11A1-IN-1(化合物30)是一种针对CYP11A1的抑制剂,其IC50为201-2000 nM。该化合物主要应用于类固醇受体研究,尤其适用于雄激素受体依赖性疾病,例如前列腺癌的研究。 | |||
T72397 |
PARP11 inhibitor ITK7
ITK7 |
||
PARP11 inhibitor ITK7 (ITK7) 为高效选择性的PARP11抑制剂,IC50为14 nM,主要用于针对PARP11的细胞定位研究。 | |||
T78033 |
SDP116
|
||
SDP116为合成的GPR116 Stachel肽衍生物,具备ADGRF5激动剂功能。 | |||
T80291 |
PP113
|
||
PP113是一种具有广谱抗菌性的抗菌肽,能有效作用于多种革兰氏阴性及革兰氏阳性细菌。对E.coli (MIC: 73.3 uM)、B. subtilis (MIC: 23.3 uM)、S. aureus (MIC: 13 uM)、S. lutea (MIC: 16.7 uM)及B. pumilus (MIC: 23.3 uM)表现出不同程度的最小抑菌浓度(MIC)。 | |||
T68254 |
WP1193
|
||
WP1193 is an inhibitor of the JAK2/STAT3 pathway. | |||
T38005 |
P11149
|
||
P11149 is a competitive, BBB-penetarated weakly, orally active and selective inhibitor of AChE. P11149 exhibits an IC50 of 1.3 μM for rat BChE/AChE. P11149, a Galanthamine derivative, demonstrates central cholinergic activity, behavioral efficacy and safety. P11149 is used in the study for Alzheimer’s disease[1]. P11149 is a GAL analog that is rapidly hydrolyzed in vivo to yield the potent AChE inhibitor, 6-DMG[1].P11149 exhibits greater s.c. bioavailability than p.o. [1].Oral P11149 in mice pr... | |||
TP1947 |
P110
|
||
Dynamin-related protein 1 (Drp1) inhibitor, inhibits Drp1 GTPase activity. Displays no effect on dynamin 1 or other mitochondrial dynamics-related proteins. Inhibits mitochondrial fission, dysfunction and reactive oxygen species (ROS) production in vitro. | |||
T10387 |
ASP1126
|
Others | Others |
ASP1126 is a selective and orally active sphingosine-1-phosphate (S1P) agonist (EC50s: 7.12 nM, 517 nM for hS1P1 and hS1P3). | |||
T14940 |
CGP11952
|
Others | Others |
CGP11952 is same the benzodiazepines in its pharmacological action and it also is an experimental benzodiazepine derivative. | |||
T23491 |
UBP1112
|
Others | Others |
group III mGlu receptor antagonist |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T19328 |
Fructo-oligosaccharide DP11/GF10
|
Others | Others |
Fructo-oligosaccharide DP11/GF10 is a fructooligosaccharide (FOS) compound with a degree of polymerization (DP) equal to 11. FOS consists of 10 fructose units connected by (2→1)-β-glycosidic bonds, with a single D-glucosyl unit present at the non-reducing end. |